The Pennant Group Appoints Brent Guerisoli as Chairman and Scott Lamb as Lead Independent Director
The Pennant Group (NASDAQ: PNTG) has announced key leadership changes to its board of directors, effective January 1, 2025. Brent Guerisoli, the company's current CEO since 2022, has been appointed as Chairman of the board, succeeding Barry Smith who will remain on the board and continue as chairman of the nominating and corporate governance committee.
Additionally, Scott Lamb has been appointed as Lead Independent Director. Lamb, who has served on Pennant's board and as chairman of its audit committee since 2019, brings valuable experience from his previous role as CFO of ICU Medical (2008-2020). Guerisoli, who has been with the organization since 2012 and joined the board in 2023, has been recognized for his inspiring leadership, consistent performance, and transparent communication.
The Pennant Group (NASDAQ: PNTG) ha annunciato importanti cambiamenti di leadership nel suo consiglio di amministrazione, a partire dal 1 gennaio 2025. Brent Guerisoli, attuale CEO dell'azienda dal 2022, è stato nominato Presidente del consiglio, succedendo a Barry Smith, che rimarrà nel consiglio e continuerà come presidente del comitato per le nomine e la governance aziendale.
Inoltre, Scott Lamb è stato nominato Direttore Indipendente Principale. Lamb, che è parte del consiglio di Pennant e presidente del suo comitato di revisione dal 2019, porta un'esperienza preziosa dal suo precedente ruolo di CFO di ICU Medical (2008-2020). Guerisoli, presente nell'organizzazione dal 2012 e entrato nel consiglio nel 2023, è stato riconosciuto per la sua leadership ispiratrice, prestazioni costanti e comunicazione trasparente.
The Pennant Group (NASDAQ: PNTG) ha anunciado cambios clave en el liderazgo de su junta directiva, que entrarán en vigor el 1 de enero de 2025. Brent Guerisoli, actual CEO de la empresa desde 2022, ha sido nombrado Presidente de la junta, sucediendo a Barry Smith, quien permanecerá en la junta y continuará como presidente del comité de nominaciones y gobernanza corporativa.
Además, Scott Lamb ha sido designado como Director Independiente Principal. Lamb, que ha formado parte de la junta de Pennant y ha sido presidente de su comité de auditoría desde 2019, aporta una valiosa experiencia de su anterior cargo como CFO de ICU Medical (2008-2020). Guerisoli, que ha estado en la organización desde 2012 y se unió a la junta en 2023, ha sido reconocido por su liderazgo inspirador, rendimiento consistente y comunicación transparente.
펜넌트 그룹 (NASDAQ: PNTG)은 2025년 1월 1일부터 발효되는 이사회에 주요 리더십 변화를 발표했습니다. 브렌트 게리솔리는 2022년부터 현재 CEO로 재직 중이며, 이사회 의장으로 임명되었습니다. 게리솔리는 바리 스미스를 이어서 의장직을 맡으며, 스미스는 이사회에 남아 지명 및 기업 거버넌스 위원회의 의장직을 계속 수행합니다.
또한, 스콧 램은 수석 독립 이사로 임명되었습니다. 램은 2019년부터 펜넌트의 이사회에서 활동하며 감사위원회 의장을 맡아 왔으며, ICU Medical의 CFO(2008-2020)로 재직했던 경험이 있습니다. 게리솔리는 2012년부터 이 조직에 몸담아왔으며, 2023년에 이사회에 합류하였고, 그의 영감을 주는 리더십, 일관된 성과 및 투명한 커뮤니케이션으로 인정받았습니다.
The Pennant Group (NASDAQ: PNTG) a annoncé des changements clés dans son leadership au sein de son conseil d'administration, à compter du 1er janvier 2025. Brent Guerisoli, l'actuel PDG de l'entreprise depuis 2022, a été nommé Président du conseil, succédant à Barry Smith, qui restera au conseil et continuera en tant que président du comité des nominations et de gouvernance d'entreprise.
De plus, Scott Lamb a été nommé Directeur Indépendant Principal. Lamb, qui fait partie du conseil de Pennant et est président de son comité d'audit depuis 2019, apporte une expérience précieuse de son précédent rôle de CFO d'ICU Medical (2008-2020). Guerisoli, présent au sein de l'organisation depuis 2012 et membre du conseil depuis 2023, a été reconnu pour son leadership inspirant, sa performance constante et sa communication transparente.
The Pennant Group (NASDAQ: PNTG) hat wichtige Führungswechsel in seinem Vorstand angekündigt, die am 1. Januar 2025 in Kraft treten. Brent Guerisoli, der seit 2022 CEO des Unternehmens ist, wurde zum Vorsitzenden des Vorstands ernannt, um Barry Smith nachzufolgen, der im Vorstand bleibt und weiterhin als Vorsitzender des Nominierungs- und Corporate Governance-Ausschusses tätig sein wird.
Zusätzlich wurde Scott Lamb zum leitenden unabhängigen Direktor ernannt. Lamb, der seit 2019 im Vorstand von Pennant und als Vorsitzender des Prüfungsausschusses tätig ist, bringt wertvolle Erfahrungen aus seiner vorherigen Rolle als CFO von ICU Medical (2008-2020) mit. Guerisoli, der seit 2012 in der Organisation ist und 2023 in den Vorstand aufgenommen wurde, wurde für seine inspirierende Führung, konstanten Leistung und transparente Kommunikation anerkannt.
- CEO Brent Guerisoli's promotion to Chairman indicates strong board confidence in current leadership
- Appointment of experienced former CFO Scott Lamb as Lead Independent Director strengthens corporate governance
- Continuity maintained with Barry Smith remaining on the board
- None.
EAGLE, Idaho, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, and senior living companies, today announced the appointment of Brent Guerisoli as Chairman of its board of directors and Scott Lamb as Lead Independent Director of its board of directors, each effective January 1, 2025. Mr. Guerisoli and Mr. Lamb are existing directors of the Company.
Mr. Guerisoli has served on Pennant’s board since 2023. He has been a key leader with the organization since 2012 and has served as its Chief Executive Officer since 2022. Mr. Guerisoli succeeds Barry Smith, who served as Chairman since February 2023. Mr. Smith will remain on the Company’s board and will continue to serve as chairman of the nominating and corporate governance committee of the board.
“The board has great confidence in Brent,” said Mr. Smith, “which he has earned through his inspiring leadership, consistent performance, and transparent communication. He will make an excellent Chairman to lead Pennant forward.”
Also effective January 1, 2025, the board has appointed Mr. Lamb as the Company’s Lead Independent Director. Mr. Lamb has served on Pennant’s board and as chairman of its audit committee since 2019. Mr. Lamb served as Chief Financial Officer of publicly traded medical device company ICU Medical, Inc. from 2008 to 2020, which provided invaluable experience and perspective that he draws on when carrying out his current board duties.
“Scott is a capable leader with a strong and respected voice on the board, which makes him an exemplary choice to serve as Lead Independent Director,” remarked Mr. Smith. “We know that under his leadership and coordination, the independent directors will be robust participants with appropriately significant influence on board decisions.”
About Pennant:
The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 122 home health and hospice agencies and 57 senior living communities located throughout Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at www.pennantgroup.com.
Contact Information
The Pennant Group, Inc.
(208) 506-6100
ir@pennantgroup.com
SOURCE: The Pennant Group, Inc.
FAQ
When will Brent Guerisoli assume his role as Chairman of PNTG?
Who did Brent Guerisoli replace as Chairman of PNTG?
What is Scott Lamb's background before becoming PNTG's Lead Independent Director?
How long has Brent Guerisoli been with The Pennant Group?
